PH&T SpA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:PH&T SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013345
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PH&T SpA (PH&T), a subsidiary of Wise SGR SpA is a pharmaceutical company that conducts research activities. The company carries out research, development and manufacturing of generic drugs for specialist therapies, medical devices and nutraceuticals. It provides difficult to formulate prescription products such as sublingual formulations, oral slow release, nasal spray, eye drops and injectable forms. PH&T’s generic products include alfuzosin, budesonide, calcitriol, desmopressin, epoprostenol, exemestane, glyceryl trinitrate, latanoprost, magestrol acetate, mometasone furoate, somatostatin, travoprost, and zoledronic acid. The company offers products in the therapeutic areas of cardiovascular, neurology, endocrine and metabolic diseases, gastrointestinal, oncology, ophthalmology, bone metabolism, corticosteroids, women health and diseases of respiratory and genitourinary system. It markets its products through licensees and distributors. PH&T is headquartered in Milan, Italy.

PH&T SpA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PH&T SpA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PH&T SpA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PH&T SpA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PH&T SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PH&T SpA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
PH&T SpA, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Wise SGR Acquires PH&T for USD18 Million 10
Partnerships 11
PH&T Enters Into Commercialization Agreement With Isu Abxis For Zoledronic Acid 11
PH&T Enters Into Commercialization Agreement With GeneTec For Zoledronic Acid 12
PH&T Enters Into Commercialization Agreement With Stada Pharma For Latanoprost And Alfuzosin 13
PH&T SpA – Key Competitors 14
PH&T SpA – Key Employees 15
PH&T SpA – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
PH&T SpA, Pharmaceuticals & Healthcare, Key Facts 2
PH&T SpA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PH&T SpA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PH&T SpA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PH&T SpA, Deals By Therapy Area, 2011 to YTD 2017 8
PH&T SpA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Wise SGR Acquires PH&T for USD18 Million 10
PH&T Enters Into Commercialization Agreement With Isu Abxis For Zoledronic Acid 11
PH&T Enters Into Commercialization Agreement With GeneTec For Zoledronic Acid 12
PH&T Enters Into Commercialization Agreement With Stada Pharma For Latanoprost And Alfuzosin 13
PH&T SpA, Key Competitors 14
PH&T SpA, Key Employees 15

★海外企業調査レポート[PH&T SpA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Samsung Engineering Co Ltd (028050):企業の財務・戦略的SWOT分析
    Samsung Engineering Co Ltd (028050) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • DNO ASA (DNO):石油・ガス:M&Aディール及び事業提携情報
    Summary DNO ASA (DNO) is an oil and gas company that provides mineral properties exploration and development services. The company's services include selective and targeted drilling, fractured carbonate plays that are characteristic of the MENA region. It also provides operations in petroleum, shipp …
  • Kansas City Power & Light Co:発電所・企業SWOT分析
    Kansas City Power & Light Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • MTS Systems Corp (MTSC):企業の財務・戦略的SWOT分析
    Summary MTS Systems Corp (MTS) is an industrial equipment supplier that offers testing and sensing solutions. The company’s products include test components, actuators and hydraulic components, controllers, grips, fixtures and accessories, hydraulic power and distribution; environmental simulation s …
  • Dai Nippon Printing Co., Ltd.:企業の戦略・SWOT・財務情報
    Dai Nippon Printing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dai Nippon Printing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Exelixis Inc (EXEL):企業の財務・戦略的SWOT分析
    Exelixis Inc (EXEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Aker ASA (AKER)-石油・ガス分野:企業M&A・提携分析
    Summary Aker ASA (Aker) is an industrial investment company, which operates through in two areas, Industrial Holdings and Financial Investments. It invests mainly in energy, environment, fisheries and marine biotech, and finance. Its Industrial Holdings include Aker Solutions ASA, Aker BP, Akastor A …
  • Tragara Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tragara Pharmaceuticals Inc (Tragara Pharmaceuticals) is a pharmaceutical company focused on the clinical and commercial development of its proprietary medicines for the treatment of various cancers. Its lead product candidate TG02, an oral multi-kinase inhibitor facilitates anti-tumor activ …
  • Premier Marketing Public Company Limited:戦略・SWOT・企業財務分析
    Premier Marketing Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Premier Marketing Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Spindletop Oil & Gas Co (SPND):石油・ガス:M&Aディール及び事業提携情報
    Summary Spindletop Oil & Gas Co (Spindletop Oil & Gas) is an oil and gas exploration and production company. The company explores, develops and produces crude oil and natural gas in North America. It owns and maintains natural gas pipeline in Texas. Spindletop Oil & Gas also operates various gas pip …
  • Peter’s Food Service Ltd:企業の戦略・SWOT・財務情報
    Peter's Food Service Ltd - Strategy, SWOT and Corporate Finance Report Summary Peter's Food Service Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • A.F. Blakemore & Son Ltd (Foodservice):企業の戦略・SWOT・財務情報
    A.F. Blakemore & Son Ltd (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary A.F. Blakemore & Son Ltd (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Heska Corp (HSKA):企業の財務・戦略的SWOT分析
    Heska Corp (HSKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • PT Gudang Garam Tbk:企業の戦略・SWOT・財務情報
    PT Gudang Garam Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Gudang Garam Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Zotefoams plc (ZTF):企業の財務・戦略的SWOT分析
    Summary Zotefoams plc (Zotefoams) is a chemical manufacturer that markets cross-linked block foams. The company offers products such as microzote, zotek F, zotek N, T tubes, plastazote, evazote, zotek peba foam, supazote, and others. It offers services such as manufacturing and distribution services …
  • Aviragen Therapeutics Inc (AVIR)-医療機器分野:企業M&A・提携分析
    Summary Aviragen Therapeutics Inc (Aviragen) is a pharmaceutical company that carries out anti-infective drug discovery, development and its commercialization to treat respiratory diseases. It has four product candidates in clinical development which address viral infections, namely, vapendavir, ora …
  • Scholastic Corp (SCHL)
    Scholastic Corp (SCHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Anthem Inc (ANTM):企業の財務・戦略的SWOT分析
    Anthem Inc (ANTM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Xped Ltd (XPE):電力:M&Aディール及び事業提携情報
    Summary Xped Ltd (Xped) formerly Raya Group Limited, is an Internet of Things company that develops software and hardware solutions. It offers auto discovery remote control, Xerts, and Xped app software; and hardware such as Xped ADRC Shields, Umbo-Xped ADRC Hub, UltraPlug, VariPlug, IRBlaster. The …
  • Scomi Group Bhd (SCOMI):企業の財務・戦略的SWOT分析
    Scomi Group Bhd (SCOMI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆